PSMA-Avid Desmoid Tumor of the Abdominal Wall on18F-Piflufolastat PET/CT

Siddharth Bommekal; Lesley Flynt; Sanjit Om Tewari; Devaki Shilpa Sudha Surasi

doi:10.1097/RLU.0000000000005269

PSMA-Avid Desmoid Tumor of the Abdominal Wall on¹⁸F-Piflufolastat PET/CT

Siddharth Bommekal, Lesley Flynt, Sanjit Om Tewari, Devaki Shilpa Sudha Surasi

Nuclear Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Prostate-specific membrane antigen (PSMA) PET/CT is widely used in the evaluation of suspected metastasis for initial definitive therapy and suspected recurrence of prostate cancer. We outline a case report of a 62-year-old man with history of prostate cancer treated with surgery, salvage radiation, and hormonal therapy presenting with rising PSA levels. There was incidental detection of a PSMA-avid subcutaneous abdominal wall mass on PSMA PET/CT study, which was consistent with desmoid fibromatosis on an ultrasound-guided biopsy.

Original language	English (US)
Pages (from-to)	672-673
Number of pages	2
Journal	Clinical nuclear medicine
Volume	49
Issue number	7
DOIs	https://doi.org/10.1097/RLU.0000000000005269
State	Published - Jul 1 2024

Keywords

F-piflufolastat PET/CT
desmoid tumor
prostate carcinoma
Pylarify

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1097/RLU.0000000000005269

Cite this

@article{f15275cd93c24a96ab1b4e80a877e71e,

title = "PSMA-Avid Desmoid Tumor of the Abdominal Wall on18F-Piflufolastat PET/CT",

abstract = "Prostate-specific membrane antigen (PSMA) PET/CT is widely used in the evaluation of suspected metastasis for initial definitive therapy and suspected recurrence of prostate cancer. We outline a case report of a 62-year-old man with history of prostate cancer treated with surgery, salvage radiation, and hormonal therapy presenting with rising PSA levels. There was incidental detection of a PSMA-avid subcutaneous abdominal wall mass on PSMA PET/CT study, which was consistent with desmoid fibromatosis on an ultrasound-guided biopsy.",

keywords = "F-piflufolastat PET/CT, desmoid tumor, prostate carcinoma, Pylarify",

author = "Siddharth Bommekal and Lesley Flynt and Tewari, {Sanjit Om} and Surasi, {Devaki Shilpa Sudha}",

year = "2024",

month = jul,

day = "1",

doi = "10.1097/RLU.0000000000005269",

language = "English (US)",

volume = "49",

pages = "672--673",

journal = "Clinical nuclear medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "7",

}

TY - JOUR

T1 - PSMA-Avid Desmoid Tumor of the Abdominal Wall on18F-Piflufolastat PET/CT

AU - Bommekal, Siddharth

AU - Flynt, Lesley

AU - Tewari, Sanjit Om

AU - Surasi, Devaki Shilpa Sudha

PY - 2024/7/1

Y1 - 2024/7/1

N2 - Prostate-specific membrane antigen (PSMA) PET/CT is widely used in the evaluation of suspected metastasis for initial definitive therapy and suspected recurrence of prostate cancer. We outline a case report of a 62-year-old man with history of prostate cancer treated with surgery, salvage radiation, and hormonal therapy presenting with rising PSA levels. There was incidental detection of a PSMA-avid subcutaneous abdominal wall mass on PSMA PET/CT study, which was consistent with desmoid fibromatosis on an ultrasound-guided biopsy.

AB - Prostate-specific membrane antigen (PSMA) PET/CT is widely used in the evaluation of suspected metastasis for initial definitive therapy and suspected recurrence of prostate cancer. We outline a case report of a 62-year-old man with history of prostate cancer treated with surgery, salvage radiation, and hormonal therapy presenting with rising PSA levels. There was incidental detection of a PSMA-avid subcutaneous abdominal wall mass on PSMA PET/CT study, which was consistent with desmoid fibromatosis on an ultrasound-guided biopsy.

KW - F-piflufolastat PET/CT

KW - desmoid tumor

KW - prostate carcinoma

KW - Pylarify

UR - http://www.scopus.com/inward/record.url?scp=85195228569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85195228569&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000005269

DO - 10.1097/RLU.0000000000005269

M3 - Article

C2 - 38739529

AN - SCOPUS:85195228569

SN - 0363-9762

VL - 49

SP - 672

EP - 673

JO - Clinical nuclear medicine

JF - Clinical nuclear medicine

IS - 7

ER -